GeoVax Company
GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.
Founded Date:
1988-01-01
Total Funding:
28048841
Employee Number:
11-50
Funding Status:
IPO
Last Funding Type:
Post-IPO Equity
Investors Number:
1
Last Funding Date:
2022-01-14
Industry:
Viral Vectors
Headquarters:
Smyrna, Georgia, United States
Estimated Revenue:
Less than $1M